Best hospitals for cancer care: A data-based guide to national rankings and patient considerations

The best hospitals for cancer care are commonly identified through national rankings, cancer-specific expertise, research activity, and measures such as outcomes and patient experience. In the 2026-27 U.S. News & World Report rankings, the leading five cancer hospitals remained unchanged from the previous year, with the University of Texas MD Anderson Cancer Center ranked first, followed by Memorial Sloan Kettering Cancer Center, Dana-Farber Brigham Cancer Center, Mayo Clinic, and Massachusetts General Hospital. 1

2026-27 national ranking leaders

MD Anderson in Houston retained the No. 1 position for cancer care for the 12th consecutive year. The center has ranked among the nation’s top two cancer hospitals since the first U.S. News survey in 1990. Its 2026-27 results also included national rankings of No. 6 in urology and No. 16 in gastroenterology and gastrointestinal surgery, along with High Performing ratings for colon cancer surgery, gynecologic cancer surgery, leukemia, lymphoma and myeloma treatment, lung cancer surgery, and prostate cancer surgery. 2

Memorial Sloan Kettering, based in New York, ranked No. 2 nationally and has held that position for the past 12 years. The remainder of the top five consisted of Dana-Farber Brigham Cancer Center in Boston, Mayo Clinic in Rochester, Minnesota, and Massachusetts General Hospital in Boston. The ranking list also placed Johns Hopkins Hospital, Hospital of the University of Pennsylvania, Northwestern Medicine-Northwestern Memorial Hospital, Stanford Health Care-Stanford Hospital, Mount Sinai Hospital, and UCSF Health-UCSF Medical Center among the top 10, including a tie for 10th. 4

What the ranking measures

National hospital rankings should be interpreted as broad comparative tools rather than guarantees of a particular treatment result. Dana-Farber reported that U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. The methodology described in that report used objective measures including risk-adjusted mortality rates, preventable complications, and patient experience, while only 16% of evaluated hospitals received a Best Hospitals designation. 5

Ranking position does not automatically identify the most appropriate hospital for every diagnosis. Cancer care is organized around disease-specific expertise, and hospitals may have distinctive strengths in blood cancers, surgery, radiation, pediatric oncology, immunotherapy, or rare tumors. MSK, for example, lists programs covering breast, lung, colorectal, gynecologic, brain, liver, pancreatic, kidney, blood, and many other cancers. A comparison therefore needs to consider the relevant cancer type, stage, treatment complexity, and clinician expertise rather than relying on a single overall rank. 8

Research, clinical trials, and comprehensive centers

Research infrastructure is a major feature of leading cancer hospitals. Mayo Clinic is described as integrating multidisciplinary cancer care with genomic research and clinical trials, while Dana-Farber combines adult and pediatric oncology treatment with research and education. These structures can be relevant when a patient is evaluating investigational therapies, molecular testing, or treatment approaches that require collaboration among surgery, medical oncology, radiation oncology, pathology, and genetics specialists. 35

The National Cancer Institute designates certain facilities as Comprehensive Cancer Centers based on excellence in research and patient care. City of Hope identifies its Los Angeles-area national center as an NCI-designated Comprehensive Cancer Center and describes a research-to-treatment model involving personalized therapies. Montefiore Einstein likewise identifies itself as an NCI-designated comprehensive cancer center, reporting care for more than 400 cancer types and more than 500 active clinical research studies. 679

Leading hospitals and their reported strengths

Each prominent institution has a different organizational profile. MD Anderson is a dedicated cancer institution with a long-standing oncology focus. MSK is a nonprofit cancer center treating many cancer subtypes across locations in New York State and New Jersey. Dana-Farber Brigham Cancer Center combines Dana-Farber Cancer Institute with Brigham and Women’s Hospital, while Mayo Clinic provides cancer care within a broader multispecialty medical system. Those differences can affect referrals, inpatient services, and coordination with other medical conditions. 238

Other nationally recognized centers may be particularly relevant for specific clinical needs. Johns Hopkins Kimmel Cancer Center is identified as an NCI-designated comprehensive cancer center, Cleveland Clinic’s Taussig Cancer Center is described as having specialized programs in blood cancers, breast cancer, and neuro-oncology, and City of Hope is associated with bone marrow transplantation and CAR T-cell therapy. Such distinctions should be checked against the diagnosis and treatment question being evaluated. 96

Regional reach and practical limitations

Geography can materially shape cancer care. The leading hospitals are concentrated in Houston, New York, Boston, Rochester, Baltimore, Philadelphia, Chicago, the San Francisco Bay Area, and Los Angeles. City of Hope reports additional cancer centers in the Atlanta, Chicago, Orange County, and Phoenix areas, while MSK has multiple locations in New York State and New Jersey. A broader footprint may reduce travel for some services, but the principal specialist or clinical trial may still be located at a specific campus. 168

Travel, insurance rules, referral procedures, appointment scheduling, caregiver availability, and continuity between local and tertiary hospitals are important sources of friction. A national ranking does not establish eligibility for a clinical trial, coverage for a therapy, or suitability for a particular operation. Treatment plans also involve ongoing monitoring, possible complications, rehabilitation, and coordination with primary care. These practical realities should be reviewed with the treating medical team and the relevant hospital’s patient-services department. 5

How to compare hospitals responsibly

A responsible comparison begins with the specific clinical question. Patients and families can examine whether the hospital routinely treats the cancer type, provides the needed surgery or systemic therapy, has relevant clinical trials, and coordinates multidisciplinary care. The number of conditions treated can indicate breadth, but breadth alone does not establish superior results for an individual patient. Published outcomes, complication measures, patient experience data, and the qualifications of the disease-focused team provide more useful context than reputation alone. 57

Questions about oversight and eligibility are equally important. NCI designation indicates a formal research and cancer-center review framework, but it is not a universal guarantee of a specific outcome. U.S. News rankings provide a national comparison based on defined measures, but they do not replace pathology review, staging, second opinions, or an individualized treatment discussion. The most defensible choice balances relevant expertise, evidence-based care, research opportunities, logistics, and the patient’s medical and personal circumstances. 910

Sources

1. Oncology News Central
2. The University of Texas MD Anderson Cancer Center
3. Verywell Health
4. Healio
5. Dana-Farber Cancer Institute
6. City of Hope
7. Montefiore Einstein Comprehensive Cancer Center
8. Memorial Sloan Kettering Cancer Center and Newswise
9. National Cancer Institute
10. U.S. News & World Report